Current Edition

Highlights From the FIPEd
Education & Training

Highlights From the FIPEd Global Education Report

The International Pharmaceutical Federation Education Initiative (FIPEd) launched the 2013 FIPEd Global Education Report (available at: www.fip.org/educationreports) in September 2013. This is the first publication …

Continue Reading →
Curricula Then and Now
Academic Affairs

Curricula Then and Now—An Environmental Scan and Recommendations

According to the Bylaws of the American Association of Colleges of Pharmacy (AACP), the Academic Affairs Committee shall consider the intellectual, social, and personal aspects …

Continue Reading →
Regional News

J&J cell therapy partner Legend carves out production foothold in Belgium as myeloma drug nears finish line

As Legend Biotech and Johnson & Johnson’s multiple myeloma cell therapy prospect nears the FDA finish line, the companies are moving to carve out a manufacturing …

Continue Reading →
Regional News

Horizon lays out $65M for in-house manufacturing plant as eye med Tepezza resets course to blockbusterland

As Horizon Therapeutics’ one-and-a-half-year-old thyroid eye disease med Tepezza starts to spread its wings, the drugmaker is standing up in-house manufacturing to help blunt any further …

Continue Reading →
Regional News

Bristol Myers inks another Revlimid patent settlement—this time with Sun Pharma—as copycats near

As Bristol Myers Squibb looks to guard Celgene’s top-selling cancer drug Revlimid from copycat competition, the company has inked a series of deals to welcome …

Continue Reading →
Regional News

Amgen dealt another blow in closely watched PCSK9 patent case against Sanofi, Regeneron

Amgen’s high-profile PCSK9 patent fight with Sanofi and Regeneron has attracted a who’s who of biopharma observers over the years, with many top companies voicing support for each side. Now, Amgen …

Continue Reading →
Regional News

Novavax’s COVID-19 shot won’t see much U.S. use, but a big global market awaits: analyst

In rapidly developing a COVID-19 vaccine—and a highly effective one at that—Novavax got the hard part right. But the logistics of manufacturing the vaccine has proven …

Continue Reading →
Regional News

Merck’s Keytruda extends life for cervical cancer patients in first-in-class win

For three years, Merck & Co.’s Keytruda has been the onlyimmuno-oncology drug allowed to treat cervical cancer. Now, thanks to a new clinical win, Merck aims to …

Continue Reading →
Regional News

EHA: Johnson & Johnson, nearing Sanofi showdown, bolsters Darzalex’s myeloma lead with ‘unprecedented’ survival data

Johnson & Johnson’s Darzalex has comfortably been the only CD38 multiple myeloma drug on the market for years until Sanofi hit the scene last year …

Continue Reading →
Regional News

Incyte hits 2nd FDA delay in span of days, this time for atopic dermatitis hopeful ruxolitinib cream

Despite back-to-back phase 3 trial wins in atopic dermatitis, Incyte’s ruxolitinib cream isn’t immune to class-wide JAK inhibitor safety scrutiny.  Incyte on Friday disclosed that the FDA has put off …

Continue Reading →